Drawing for COVIVIO

USPTO serial 79335131

COVIVIO

Reviewed by CopyMark Law Group

Reg. 7039231Status 700Registered
Filing date
Status date
Registration date
May 2, 2023
Examiner
HOLLAND, JAMI ELENA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with COVIVIO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nicholas D. Wells

Nicholas D. Wells Legends Law Group, PLLC330 Main St.Kaysville, UT 84037UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Downloadable computer software programs for the transmission, viewing, and storing of medical information and content, and for collecting, analyzing, and managing user medical data, all in the field of medical information and content; Downloadable computer software programs for database management and managing of textual and visual content distribution and display in the administration of scientific content; Downloadable computer programs, namely, computerized interactive software for patients and specialized medical personnel for facilitating communication between patients and medical personnel, for collecting, analyzing, and managing personal medical data of users, for facilitating medical personnel access to and use of medical data, all in supporting doctor-patient-communication, patient compliance and for supporting patients in issues of lifestyleACTIVE—
041Educational services, namely, providing online classes, seminars, and workshops via non-downloadable software in the field of medicine; Continuing educational services, namely, providing online internet-based classes, seminars, and workshops to medical patients and specialized medical personnel in the fields of adherence to standards of care, compliance with regulations, and understanding and addressing lifestyle choices of patientsACTIVE—
042Creating and developing computer programs for semantic linking and enabling the presentation of scientific data and facilitating decision making by users; technological services, namely, research in the field of using technology to facilitate patient wellness and medical diagnosis and treatment; creation of computer programsACTIVE—
044Medical services, namely, medical information and content for patients and specialized medical personnel, in order to encourage and train them in the field of adherence and compliance regarding the medical issuesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 27, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 9, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 9, 2023FIMPFINAL DISPOSITION PROCESSED—
Aug 2, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jun 23, 2023RNWLINTERNATIONAL REGISTRATION RENEWED—
May 2, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 2, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 26, 2023ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Dec 13, 2022ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 15, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 15, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 26, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 13, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 13, 2022XAECEXAMINER'S AMENDMENT ENTERED—
Oct 13, 2022GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 13, 2022GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 13, 2022CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 4, 2022RFNTREFUSAL PROCESSED BY IB—
Aug 23, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 22, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 22, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 17, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 17, 2022RFRRREFUSAL PROCESSED BY MPU—
Aug 14, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 13, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 12, 2022DOCKASSIGNED TO EXAMINER—
Mar 8, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 4, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 3, 2022SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance